Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1G244 是DPP8/9的抑制剂,具有抗动脉粥样硬化和抗骨髓瘤作用的特性。1G244对DPP8和DPP9的IC50值分别为14和53 nM, DPP8和DPP9的Ki 值分别为0.9和4.2 nM
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 247 | 现货 | ||
5 mg | ¥ 555 | 现货 | ||
10 mg | ¥ 897 | 现货 | ||
25 mg | ¥ 1,830 | 现货 | ||
50 mg | ¥ 2,960 | 现货 | ||
100 mg | ¥ 4,760 | 现货 | ||
500 mg | ¥ 9,860 | 现货 |
产品描述 | 1G244 is an inhibitor of DPP8/9 with antiatherosclerotic and antimyeloma properties. 1G244 had the IC50 values of 14 and 53 nM against DPP8 and DPP9, and The Ki values for 1G244 were 0.9 and 4.2 nM for DPP8 and DPP9 |
靶点活性 | DPP9:53 nM, DPP8:14 nM, DPP8:0.9 nM(ki), DPP9:4.2 nM(ki) |
体外活性 | 1G244 (0-100 μM) dose-dependently decreased viable cell number of five multiple myeloma cell lines as well as three T-cell lymphoma cell lines[2]. |
体内活性 | The apoE−/− mice treated with 1G244 (1G244 dissolved in 75% PEG 300, 2 mg/kg) showed that 1G244 reduced the area of advanced atherosclerotic lesions by about 14%[1]. 1G244 was administered subcutaneously into mice at 30 mg/kg once a week, administration of 1G244 apparently suppressed the subcutaneous growth of MM.1 S cells[2]. |
分子量 | 504.57 |
分子式 | C29H30F2N4O2 |
CAS No. | 847928-32-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 225.0 mg/mL (445.9 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.9819 mL | 9.9094 mL | 19.8189 mL | 49.5471 mL |
5 mM | 0.3964 mL | 1.9819 mL | 3.9638 mL | 9.9094 mL | |
10 mM | 0.1982 mL | 0.9909 mL | 1.9819 mL | 4.9547 mL | |
20 mM | 0.0991 mL | 0.4955 mL | 0.9909 mL | 2.4774 mL | |
50 mM | 0.0396 mL | 0.1982 mL | 0.3964 mL | 0.9909 mL | |
100 mM | 0.0198 mL | 0.0991 mL | 0.1982 mL | 0.4955 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
1G244 847928-32-9 Proteases/Proteasome Ubiquitination Proteasome 1G-244 1G 244 Inhibitor inhibitor inhibit